Delivery Order SPE2DB24D2205-SPE2DB24FDSHZ
- Not listed
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,096,109 units of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The delivery order has a ceiling value of $4,647.12 and an ultimate completion date of March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,290,496 units of MONOVISC 88 MG/4 ML SYRINGE 4ML, with a total ceiling value of $2,671.26. The delivery order has an ultimate completion date of May 20, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation mentioned. This...
- This is a firm fixed price delivery order award by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with a total ceiling value of $5,583.45 and a period of performance through April 8, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The award has a potential value of $4,647.12 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not subject to any set-aside designations. The company also...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract has a firm fixed price of $10,704.62 and a completion date of September 13, 2024. AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, is the prime contractor. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract is a Firm Fixed Price (FFP) agreement with a ceiling value of $15,163.97 and an ultimate completion date of September 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $20,640.12, is for the delivery of 4,564,084,975 units of the MONOVISC 88 MG/4 ML SYRINGE 4ML pharmaceutical product. The contract has a period of performance through March 27, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $8,390.35 contract is for the supply of "MONOVISC 88 MG/4 ML SYRINGE 4ML", a specialty pharmaceutical product. The delivery order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen holds with DLA. This...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The award has a ceiling value of $11,387.31 and a period of performance through April 9, 2024. This order is placed against an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The award, valued at $4,647.12, is for the provision of a single item - the MONOVISC 88 MG/4 ML SYRINGE 4ML pharmaceutical product. The delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential ceiling...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB24FDSHZDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The delivery order has a ceiling value of $10,889.48 and a completion date of April 10, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside designation. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 4/9/24 |